R&D INTENSITY AND IPO UNDERPRICING: CASE STUDY ON PHARMACEUTICAL AND BIOTECH INDUSTRIES IN THE US

Tommy C. Efrata

Abstract


Asymmetric information between the issuer to potential investors believed by some academics in finance as one of the main causes of the phenomenon of underpricing at the time of the initial public offering (IPO). On science and technology-based company main problem lies in how to conduct assessments on the future value of a product that is still in the development stage. The issue became more prominent on pharmaceutical companies and biotechnology, due to the characteristics of this industry is the high expense, complex process, and the lengthy process of research and development (R & D) of a product. This study describes the characteristics above is associated with the phenomenon of underpricing when companies conduct IPO. The samples are 82 pharmaceutical companies and biotechnology conduct IPO in the United States stock market in 1998-2005. The results of this study revealed a negative correlation between the intensity of R & D and IPO underpricing phenomenon in this industry. These studies have identified R & D as the main source of information asymmetry that led to the phenomenon of underpricing for pharmaceutical companies and biotechnology.


Keywords


Underpricing; Asymmetric Information; R & D Intensity; Pharmaceutical and Biotechnology; IPO

Full Text:

Download Article

References


Aboody, D. and B. Lev (2000), “Information Asymetry, R&D, and Insider Gain”, The Journal of Finance, Vol. LV No. 6 (Dec. 2000), pp 2747-2766.

Carter, R. and S. Manaster (1990), “Initial Public Offering and Underwriter Reputation”, Journal of Finance, Vol. 45 No. 4 (Sept. 1990), pp. 1045-1067.

Cassimon, D., Engelen, P.J., Thomassen L. and van Wouwe M. (2004), “The Valuation of NDA Using a 6-fold Compound Option”, Research Policy, No. 33 (2004), pp.41-51.

Chan, K., J. Lakoniskok and T Sougianis (2001), “The Stock Market Valuation of Research and Development Expenditure”, Journal of Finance, Vol. 56 pp 2431-2456.

Cumming, D.J. and J.G. Macintosh (2000), “The Determinants of R&D Expenditures: A Study of the Canadian Biotech Industry”, Review of Industrial Organization, No. 17/2000 pp. 357-370.

De Maeseneire, W., S. Manigart (2002), “Initial Returns: Underpricing or Overvaluation? Evidence from Easdaq and EuroNM”, Working Paper (University of Gent).

DiMasi, J.A., R.W. Hansen and H.G. Grabowski (2003), “The Price of Innovation: New Estimate of Drug Development Cost”, Journal of Health Economics, Vol. 22/2003, pp 151-185.

Garnier, J.P. (2008), “Rebuilding the R&D Engine in Big Pharma”, Havard Business Review, May 2008, pp. 69-76.

Grinblatt, M. and C. Hwang (1989), “Signaling and the Pricing of New Issues”, Journal of Finance, Vol. 44 No. 2 (June 1989), pp. 392-420.

Grabowski, H. and J. Vernon (2000), “The Determinants of Pharmaceutical Research and Development Expenditures, Journal of Evolutionary Economics, Vol. 10/2000, pp 201-215.

Guo, R., B. Lev and C. Shi (2006), “Explaining the Short and Long Term IPO Anomalies in the US by R&D”, Journal of Business Finance & Accounting, Vol. April/May 2006, pp. 550-579.

Loughran, T. and J.R. Ritter (2004), “Why Has IPO Underpricing Changed Over Time?”, Financial Management, Autumn 2004, pp. 5-37.

Megginson, W.L. and K.A. Weiss (1991), “Venture Capitalist Certification in Initial Public Offering”, Journal of Finance, Vol. 46 No. 3 (July 1991), pp. 879-903.

PhARMA, (2007), Pharmaceutical Industry Profile 2007.

Pukthuanthong, K. (2005), “Biotech IPO Valuation: R&D, Human Capital Quality, Underwriter Education”, Working Paper, San Diego State University.

Ross, S.A., R.W. Westerfield and J. Jaffe (2003), Corporate Finance, 7th edition, McGraw-Hill.

Ritter, J.R. (2003), “Difference between European and American IPO Market”, European Financial Management, Vol. 9, No. 4 pp 421-434.

Ritter, J.R. (2002), “Investment Banking and Security Issuance”, Handbook of Economic of Finance, North Holland.

Ritter, J.R. (1998), “Initial Public Offering”, Contemporary Finance Digest, Vol. 2 No. 1 (Spring 1998), pp 5-30.

Wooldridge, J.M. (2003), Introductory to Econometrics, a Modern Approach, 2nd edition, Thomson South-Western.


Refbacks

  • There are currently no refbacks.


Bookmark and Share


Office:
Ruang Jurnal Fakultas Ekonomi dan Bisnis UMY
Gedung Ki Bagus Hadikusuma (E4) Lantai 2, Kampus Terpadu Universitas Muhammadiyah Yogyakarta,
Jalan Brawijaya (Lingkar Selatan), Tamantirto, Kasihan, Bantul, Daerah Istimewa Yogyakarta, Indonesia, 55183
Website: journal.umy.ac.id/index.php/ai - E-mail: jai@umy.ac.id

Journal of Accounting and Investment is licensed under Creative Commons Attribution Attribution-NonCommercial-NoDerivatives 4.0 International License

View My Stats